Publications by authors named "Xun Lin"

Objective: Breast ultrasound (BUS) is used to classify benign and malignant breast tumors, and its automatic classification can reduce subjectivity. However, current convolutional neural networks (CNNs) face challenges in capturing global features, while vision transformer (ViT) networks have limitations in effectively extracting local features. Therefore, this study aimed to develop a deep learning method that enables the interaction and updating of intermediate features between CNN and ViT to achieve high-accuracy BUS image classification.

View Article and Find Full Text PDF

Recently, a surge in image manipulations in scientific publications has led to numerous retractions, highlighting the importance of image integrity. Although forensic detectors for image duplication and synthesis have been researched, the detection of image splicing in scientific publications remains largely unexplored. Splicing detection is more challenging than duplication detection due to the lack of reference images and more difficult than synthesis detection because of the presence of smaller tampered-with areas.

View Article and Find Full Text PDF

Purpose: To prove more accurately that Chinese herbal bath therapy may be a safe, effective, simple alternative treatment modality for knee OA, we designed a randomized, double-blind, placebo-controlled trial to explore the effectiveness of SSBD for the relief of pain, daily activities, and quality of life in patients with knee OA.

Patients And Methods: A single-center, 52-week, randomized controlled trial of SSBD versus placebo is being performed. A total of 200 patients with symptomatic knee OA will be randomly allocated to the SSBD treatment or placebo intervention group for 4 weeks.

View Article and Find Full Text PDF

Biomass burning is a primary source of atmospheric nitrogen oxide (NO), however, the lack of isotopic fingerprints from biomass burning limits their use in tracing atmospheric nitrate (NO) and NO. A total of 25 biomass fuels from 10 provinces and regions in China were collected, and the δN values of biomass fuels (δN-biomass) and δN-NO values of biomass burning (δN-NO values of BB, open burning, and rural cooking stove burning) were determined. The δN-NO values of open burning and rural cooking stove burning ranged from -0.

View Article and Find Full Text PDF

What Is This Summary About?: This summary describes the results from the TALAPRO-2 research study (also known as a clinical trial). The TALAPRO-2 study tested the combination of two medicines called talazoparib plus enzalutamide. This combination of medicines was used as the first treatment for adult patients with metastatic castration-resistant prostate cancer.

View Article and Find Full Text PDF

Immune tolerance mechanisms are shared in cancer and pregnancy. Through cross-analyzing single-cell RNA-sequencing data from multiple human cancer types and the maternal-fetal interface, we found B7-H4 (VTCN1) is an onco-fetal immune tolerance checkpoint. We showed that genetic deficiency of B7-H4 resulted in immune activation and fetal resorption in allogeneic pregnancy models.

View Article and Find Full Text PDF

Background: In the course of China's modernization, the sports industry's advancement plays a dual role in enhancing national health and driving economic transformation. The integration and coalescence of the sports and health sectors have emerged as pivotal avenues for the structural elevation of China's sports industry. Hence, empirically scrutinizing the influential mechanisms and outcomes of sports and health industry integration on the sports industry's structural enhancement holds substantial practical significance.

View Article and Find Full Text PDF
Article Synopsis
  • Preclinical studies indicate a link between the androgen receptor and poly(ADP-ribose) polymerase in prostate cancer, suggesting that inhibiting both may effectively treat metastatic castration-resistant prostate cancer (mCRPC).
  • The TALAPRO-2 phase 3 study compared the effects of combining talazoparib (a poly(ADP-ribose) polymerase inhibitor) with enzalutamide against enzalutamide alone, specifically focusing on patients with DNA damage response gene alterations.
  • Results showed that the combination therapy significantly extended radiographic progression-free survival for patients with homologous recombination repair (HRR) deficiencies, with the talazoparib group not reaching median survival at the time of
View Article and Find Full Text PDF

This study systematically reviewed the clinical efficacy of acupuncture for lumbar myofascial pain syndrome. The randomized controlled trials (RCTs) regarding acupuncture for lumbar myofascial pain syndrome were searched in PubMed, Cochrane Library, Web of Science, EMbase, Scopus, China national knowledge infrastructure (CNKI), Wanfang database, VIP database, and China biomedical literature service system (SinoMed) from database inception until August 1st, 2022. The Cochrane's risk of bias assessment tool was used to assess the risk of bias in all included studies, and Review Manager 5.

View Article and Find Full Text PDF
Article Synopsis
  • The PROSPER study focused on men with advanced prostate cancer known as non-metastatic castration-resistant prostate cancer (nmCRPC), where cancer persists despite hormone treatments.
  • Participants received either enzalutamide, a drug that inhibits androgens, or a placebo alongside androgen deprivation therapy (ADT).
  • Results showed that patients who experienced a significant decline in prostate-specific antigen (PSA) levels after enzalutamide treatment lived longer and had a lower chance of cancer spreading, indicating that PSA changes can help tailor monitoring strategies for these patients.
View Article and Find Full Text PDF

Background: Co-inhibition of poly(ADP-ribose) polymerase (PARP) and androgen receptor activity might result in antitumour efficacy irrespective of alterations in DNA damage repair genes involved in homologous recombination repair (HRR). We aimed to compare the efficacy and safety of talazoparib (a PARP inhibitor) plus enzalutamide (an androgen receptor blocker) versus enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC).

Methods: TALAPRO-2 is a randomised, double-blind, phase 3 trial of talazoparib plus enzalutamide versus placebo plus enzalutamide as first-line therapy in men (age ≥18 years [≥20 years in Japan]) with asymptomatic or mildly symptomatic mCRPC receiving ongoing androgen deprivation therapy.

View Article and Find Full Text PDF

Objective: To investigate the effects of the apolipoprotein E (APOE) gene on oxygen saturation and cerebral perfusion in the early stages of traumatic brain injury (TBI).

Methods: This study included 136 consecutive TBI patients and 51 healthy individuals. The APOE genotypes of all subjects were determined using quantitative fluorescence polymerase chain reaction (QF-PCR).

View Article and Find Full Text PDF

Aims: The aim of this study was to explore the relationship between the application of learning strategies and the emergence of higher-order learning behaviours among medical students in Chinese provincial undergraduate colleges, while also examining the impact of social demographic variables on the development of higher-order learning behaviours and learning strategy preferences.

Methodology: We conducted a relevant cross-sectional study using the Chinese College Student Survey (CCSS) online questionnaire to evaluate higher-order learning behaviours and learning strategies in medical undergraduate students attending provincial colleges in China. A total of 992 valid questionnaires were collected and analysed using SPSS 22.

View Article and Find Full Text PDF

Purpose: This post hoc analysis of PROSPER evaluated the relationship between depth of PSA decline and clinical outcomes in enzalutamide-treated men with nonmetastatic castration-resistant prostate cancer.

Materials And Methods: PROSPER was an international, randomized, double-blind, placebo-controlled, phase 3 trial that demonstrated significantly improved metastasis-free survival and overall survival with androgen deprivation therapy plus enzalutamide vs placebo. A total of 905 enzalutamide-treated men were included in this post hoc analysis.

View Article and Find Full Text PDF

The success of tumor immunotherapy highlights the potential of harnessing immune system to fight cancer. Activating both native T cells and exhausted T cells is a critical step for generating effective antitumor immunity, which is determined based on the efficient presentation of tumor antigens and co-stimulatory signals by antigen-presenting cells, as well as immunosuppressive reversal. However, strategies for achieving an efficient antigen presentation process and improving the immunosuppressive microenvironment remain unresolved.

View Article and Find Full Text PDF

What Is This Summary About?: This is a summary of a research article originally published in . The PROSPER study involved men who had a type of advanced prostate cancer called nonmetastatic castration-resistant prostate cancer (nmCRPC). In men with nmCRPC, their cancer has progressed on traditional hormone therapy but scans show that it has not spread to other parts of the body.

View Article and Find Full Text PDF

Multigene assays can provide insight into key biological processes and prognostic information to guide development and selection of adjuvant cancer therapy. We report a comprehensive genomic and transcriptomic analysis of tumor samples from 171 patients at high risk for recurrent renal cell carcinoma post nephrectomy from the S-TRAC trial (NCT00375674). We identify gene expression signatures, including STRAC11 (derived from the sunitinib-treated population).

View Article and Find Full Text PDF

The Th17 cell-lineage-defining cytokine IL-17A contributes to host defense and inflammatory disease by coordinating multicellular immune responses. The IL-17 receptor (IL-17RA) is expressed by diverse intestinal cell types, and therapies targeting IL-17A induce adverse intestinal events, suggesting additional tissue-specific functions. Here, we used multiple conditional deletion models to identify a role for IL-17A in secretory epithelial cell differentiation in the gut.

View Article and Find Full Text PDF

PARP inhibitors in combination with androgen receptor-targeted therapy have demonstrated potential in the treatment of metastatic castration-resistant prostate cancer (mCRPC). Here, we describe the design and rationale of the multinational, phase III, two-part TALAPRO-2 study comparing talazoparib plus enzalutamide versus placebo plus enzalutamide as a first-line treatment for patients with mCRPC with or without DNA damage response (DDR) alterations. This study has two co-primary end points: radiographic progression-free survival (rPFS) by blinded independent clinical review in all-comers (cohort 1) and in patients with DDR alterations (cohort 2).

View Article and Find Full Text PDF

Polygon tilings in natural and man-made objects show great variety. Unlike previous studies that have mainly focused on their classification and production methods, this study aimed at exploring factors that may contribute to the perceived beauty of convex polygon tilings. We analyze the dimensions of regularity, curvature, and density, as well as individual differences.

View Article and Find Full Text PDF

Background: Enzalutamide combined with androgen deprivation therapy (ADT) significantly prolonged metastasis-free survival and overall survival (OS) versus ADT alone in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) with rapidly rising prostate-specific antigen (PSA). The objective of this post hoc analysis of the PROSPER trial is to evaluate OS benefit and safety of enzalutamide in patients across age and regional subgroups.

Patients And Methods: Eligible men with nmCRPC, PSA doubling time ≤10 months and PSA ≥2 ng/mL with continued ADT use were randomised 2:1 to enzalutamide 160 mg or placebo.

View Article and Find Full Text PDF

As a biodegradable material, black phosphorus (BP) has been considered as an efficient agent for cancer photothermal therapy. However, its systemic delivery faces several hurdles, including rapid degradation in blood circulation, quick clearance by the immune system, and low delivery sufficiency to the tumor site. Here, we developed a biomimetic nanoparticle platform for tumor-targeted delivery of BP nanosheets (BP NSs).

View Article and Find Full Text PDF

Background: Pancreatic metastases (PM) are rare in renal cell carcinoma. It has been suggested that patients with metastases to the pancreas have a more favorable prognosis, but little is known about the long-term outcomes with systemic therapy. We sought to understand the outcomes of patients with metastatic renal cell carcinoma with PM treated with systemic therapy.

View Article and Find Full Text PDF

A PHP Error was encountered

Severity: 8192

Message: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated

Filename: helpers/my_audit_helper.php

Line Number: 8900

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 8900
Function: str_replace

File: /var/www/html/application/controllers/Author.php
Line: 786
Function: formatAIDetailSummary

File: /var/www/html/application/controllers/Author.php
Line: 685
Function: pubMedSearchtoAuthorResults_array

File: /var/www/html/application/controllers/Author.php
Line: 122
Function: pubMedAuthorSearch_array

File: /var/www/html/index.php
Line: 316
Function: require_once